TrialMenopause (New York, N.Y.)2020

Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial.

Mike Trower et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.